hypercalcemia
HYPERCALCEMIA
Hypercalcemia is having serum calcium level of >10.5 mg/dL (>2.5 mmol/L).
Mild hypercalcemia is usually asymptomatic. While, more severe hypercalcemia has a constellation of clinical manifestations commonly described as "bones, abdominal moans, stones & groans."
Etiologies may be parathyroid-dependent or parathyroid independent.
Surgery is the treatment of choice for hypercalcemic patients with classic symptoms or complications of primary hyperparathyroidism.

Principles of Therapy

  • Surgery is the treatment of choice for patients w/ classic symptoms or complications of primary hyperparathyroidism

Pharmacotherapy

  • There is no convincing data to support the effectiveness of medical therapy in long-term management of primary hyperparathyroidism

Primary Hyperparathyroidism

Estrogen Replacement

  • In postmenopausal women, estrogen replacement may lower serum Ca w/ no effect on PTH
  • Protects against bone loss

Bisphosphonates

  • Further study is needed to prove usefulness in mild hypercalcemia caused by primary hyperparathyroidism

Acute Severe Hypercalcemia

Loop Diuretics

  • Administer as aggressively as patient’s cardiac status will allow
  • Effects: Stimulates natriuresis which is accompanied by calciuresis
    • Direct calciuretic effects may be achieved w/ high doses (Furosemide 100 mg/hr)
    • Serum Ca may decrease by ≥1 mmol/L (4 mg/dL) w/in 24 hr
    • Urine Ca excretion may exceed >25 mmol/dL

Bisphosphonates

  • Actions: High affinity for bone esp in areas of increased bone turnover where they inhibit bone resorption
  • Useful for hypercalcemia due to enhanced osteoclastic bone resorption
  • Effects: Depending on agent used may take a few days to reach normocalcemia
    • Normocalcemia is prolonged (depending on agent, may be for a mth or longer)
  • Though related structurally, bisphosphonates differ in potency, efficacy, route of administration, toxicity & side effects

Calcitonin

  • Actions: Blocks bone resorption through receptors on osteoclasts, increases urinary Ca excretion by blocking renal tubular Ca reabsorption
  • Effects: Can be seen w/in a few hr of administration
    • Minimal lowering of serum Ca
  • May use in combination w/ rehydration & saline diuresis w/in the 1st 24 hr of treatment until bisphosphonates take effect

Corticosteroid Hormones

  • Actions: In pharmacologic doses cause an increase in urinary Ca excretion & decrease in intestinal Ca absorption
    • Cause negative skeletal Ca balance
    • May also have a direct cytolytic effect on some tumor cells
  • Effects: Hypocalcemic effect develops over several days
  • Benefit is seen in hypercalcemia caused by certain osteolytic malignancies, multiple myeloma, leukemia, breast cancer & Hodgkin’s disease
  • Effective in treating hypercalcemia caused by Vit D intoxication & sarcoidosis

Vitamin D Intoxication

  • Discontinue Vit D
  • Restrict dietary Ca intake
  • Ensure adequate hydration

Granulomatous Diseases

  • Avoid excessive sunlight exposure
  • Limit Ca & vit intake

Other Drug for Hypercalcemia

Cinacalcet

  • A calcimimetic agent indicated for hypercalcemic patients w/ parathyroid carcinoma
  • It directly lowers PTH levels by increasing the sensitivity of the Ca-sensing receptor on the parathyroid gland; results in concomitant decrease in serum Ca
  • Clinical trials have shown prolonged normalization of serum Ca levels

Measures to Lower Serum Calcium

Mild Asymptomatic Hypercalcemia
  • Patients w/ primary hyperparathyroidism often have mild & prolonged hypercalcemia, which results in mild or no symptoms
  • Start measures to decrease serum Ca
    • Stop any medications that may cause hypercalcemia eg thiazide diuretics
    • Patient should avoid all diuretics
  • Counsel patient to:
    • Avoid prolonged immobilization
    • Maintain adequate hydration
    • Patient should seek immediate medical attention for illness that may cause dehydration esp severe vomiting or diarrhea
  • If patient becomes symptomatic, they should be referred to a surgeon immediately
Acute Severe Hypercalcemia
  • Monitor patient closely preferably in ICU setting esp if using forced diuresis
    • Monitor central venous pressure, plasma or urine electrolytes, may need to catheterize the bladder
  • Diagnostic testing should occur while aggressive Ca-lowering treatment is initiated
  • Primary hyperparathyroidism will benefit from immediate surgery
Fluids
  • Restore normal hydration
    • Patient is usually dehydrated from vomiting, inanition or defective urinary concentrating ability
  • If serum Ca >2.8 mmol/L (11.2 mg/dL), patient needs to be instructed to drink 2-3 L/day of low Ca liquids
  • If serum Ca >3 mmol/L (12 mg/dL)
    • Infuse NaCl 0.9% at 2-6 L/day IV which will increase calciuria
    • Loop diuretic may be added to improve diuresis
  • K & Mg depletion needs to be prevented
If diuresis proves unsuccessful:
  • Hemodialysis is the treatment of choice
  • Dialysis bath should be free of or low in Ca
  • Effects of dialysis: Ca-free peritoneal dialysis can remove 5-12.5 mmol (200-500 mg) of Ca in 24-48 hr
    • Serum Ca may be lowered by 0.7-3 mmol/L (3-12 mg/dL)
  • Phosphate conc needs to be monitored
    • Add phosphate supplements to diet if necessary
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
25 Aug 2015
At the Northern Pharmacists Convention cum 48th Malaysian Pharmaceutical Society Seminar 2015 held recently at Bayview Beach Hotel, Penang, Sanofi invited three distinguished speakers – Dr Khaw Chong Hui, Dr Lo Kang Shang Chit, and Professor Dr Karl-Josef Gundermann – to speak on the importance of renal protection in managing diabetic hypertension, the use of antihistamines in managing chronic urticaria (CU), and the role of essential phospholipids (EPL) in fatty liver diseases, respectively.
Roshini Claire Anthony, 07 Nov 2017

Women who are underweight, particularly in their late teens and mid-thirties, may be at risk for early menopause, a recent study found. 

2 days ago
Oestradiol therapy appears to protect certain types of cognition in the presence of stress, suggests a recent study.
17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.